Orally Active Macrocyclic Peptides as Analgesics
Jane V. Aldrich received a B.S. in biochemistry from Michigan State University and her Ph.D. in medicinal chemistry from the University of Michigan. She was an NIH postdoctoral fellow at the University of Minnesota where she began her research on opioid peptides with Dr. Philip Portoghese. She rose through the faculty ranks at Oregon State University and University of Maryland Baltimore prior to moving to the University of Kansas as a professor of medicinal chemistry in 2001.
Dr. Aldrich's research focuses on the design and synthesis of peptide and peptidomimetic analogs of opioid peptides, along with the development of synthetic methods to prepare these analogs. Her funding from the National Institute on Drug Abuse has included an Independent Scientist Award (1998-2009).
Dr. Aldrich has served the Medicinal Chemistry Division as Vice Chair (1999), Chair (2000) and Past Chair (2001) as well as on Division committees (Long Range Planning Committee 1995-1997, Graduate Fellowship Committee 1996-1998). She also has been active in the American Peptides Society (Councilor 2001-2007, President Elect 2003-2005, President 2005-2007 and Past President 2007-2009) and served as Co-vice Chair (2002) and Co-chair (2004) of the Gordon Research Conference on the Chemistry and Biology of Peptides. In addition she has served on the editorial board of several journals, including the Journal of Medicinal Chemistry (2000-2004), and was an editor of the journal Letters in Peptide Science (1994-2004).